Page last updated: 2024-11-05

thiotepa and Polyneuropathy, Acquired

thiotepa has been researched along with Polyneuropathy, Acquired in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research Excerpts

ExcerptRelevanceReference
"Women with metastatic breast cancer and at least a partial response (PR) to induction chemotherapy received three separate high-dose cycles of chemotherapy with peripheral blood progenitor support and G-CSF."6.70Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer. ( Antman, K; Balmaceda, C; Donovan, D; Frederick, D; Haythe, J; Hesdorffer, CS; Kaufman, E; Nichols, G; Papadopoulos, K; Savage, D; Sharpe, E; Tiersten, A; Troxel, A; Vahdat, LT, 2002)
"Women with metastatic breast cancer and at least a partial response (PR) to induction chemotherapy received three separate high-dose cycles of chemotherapy with peripheral blood progenitor support and G-CSF."2.70Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer. ( Antman, K; Balmaceda, C; Donovan, D; Frederick, D; Haythe, J; Hesdorffer, CS; Kaufman, E; Nichols, G; Papadopoulos, K; Savage, D; Sharpe, E; Tiersten, A; Troxel, A; Vahdat, LT, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vahdat, LT1
Balmaceda, C1
Papadopoulos, K1
Frederick, D1
Donovan, D1
Sharpe, E1
Kaufman, E1
Savage, D1
Tiersten, A1
Nichols, G1
Haythe, J1
Troxel, A1
Antman, K1
Hesdorffer, CS1

Trials

1 trial available for thiotepa and Polyneuropathy, Acquired

ArticleYear
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
    Bone marrow transplantation, 2002, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cy

2002